期刊文献+
共找到1,008篇文章
< 1 2 51 >
每页显示 20 50 100
Identification of an epitope of SARS-coronavirus nucleocapsid protein 被引量:22
1
作者 YINGLIN XuSHEN +16 位作者 RUIFuYANG YIXUELI YONGYONGJI YouYuHE MuDESHI WEILU TIELIUSHI BINGSUN JINWANG HONGXIAWANG HUALIANGJIANG JIANHUASHEN YOUHUAXIE YUANWANG GANGPEI BBIFENSHEN JIARUIWU 《Cell Research》 SCIE CAS CSCD 2003年第3期141-145,共5页
The nueleocapsid (N) protein of severe acute respiratory syndrome-coronavirus (SARS-CoV) is a major virion structural protein. In this study, two epitopes (Nl and N2) of the N protein of SARS-CoV were predicted by bio... The nueleocapsid (N) protein of severe acute respiratory syndrome-coronavirus (SARS-CoV) is a major virion structural protein. In this study, two epitopes (Nl and N2) of the N protein of SARS-CoV were predicted by bioinformatics analysis. After immunization with two peptides, the peptides-specific antibodies were isolated from the immunized rabbits. The further experiments demonstrated that N1 peptide-induced polyclonal antibodies had a high affinity to bind to E. coli expressed N protein of SAR,S-CoV. Furthermore, it was confirmed that Nl peptide-specific IgG antibodies were detectable in the sera of severe acute respiratory syndrome (SARS) patients. The results indicated that an epitope of the N protein has been identified and N protein specific Abs were produced by peptide immunization, which will be useful for the study of SARS-CoV. 展开更多
关键词 severe acute respiratory syndrome-coronavirus necleocapsid protein EPITOPE polyclonal antibody antiserum.
下载PDF
Severe acute respiratory syndrome-associated coronavirus genotype and its characterization 被引量:4
2
作者 李兰娟 王志刚 +21 位作者 卢亦愚 包其郁 陈苏红 吴南屏 程苏云 程苏云 翁景清 张严峻 严菊英 梅玲玲 王晓萌 朱函坪 余迎朴 张敏丽 李敏红 姚军 陆群英 姚苹苹 伯晓晨 沃健尔 王升启 胡松年 《Chinese Medical Journal》 SCIE CAS CSCD 2003年第9期1288-1292,共5页
Objective To study the severe acute respiratory syndrome (SARS) -associated coronavirus genotype and its characteristics.Methods A SARS-associated coronavirus isolate named ZJ01 was obtained from throat swab samples t... Objective To study the severe acute respiratory syndrome (SARS) -associated coronavirus genotype and its characteristics.Methods A SARS-associated coronavirus isolate named ZJ01 was obtained from throat swab samples taken from a patient in Hangzhou, Zhejing province. The complete genome sequence of ZJ01 consisted of 29 715 bp (GenBank accession: AY297028, version; gi: 30910859). Seventeen SARS-associated coronavirus genome sequences in GenBank were compared to analyze the common sequence variations and the probability of co-occurrence of multiple polymorphisms or mutations. Phylogenetic analysis of those sequences was done.Results By bioinformatics processing and analysis, the 5 loci nucleotides at ZJ01 genome were found being T, T, G, T and T, respectively. Compared with other SARS-associated coronavirus genomes in the GenBank database, an A/G mutation was detected besides the other 4 mutation loci (C: G: C: C/T: T: T: T) involved in this genetic signature. Therefore a new definition was put forward according to the 5 mutation loci. SARS-associated coronavirus strains would be grouped into two genotypes (C: G: A: C: C/T: T: G: T: T), and abbreviated as SARS coronavirus C genotype and T genotype. On the basis of this new definition, the ZJ01 isolate belongs to SARS-associated coronavirus T genotype, first discovered and reported in China's Mainland. Phylogenetic analysis of the spike protein gene fragments of these SARS-associated coronavirus strains showed that the GZ01 isolate was phylogenetically distinct from other isolates, and compared with groups F1 and F2 of the T genotype, the isolates of BJ01 and CUHK-W1 were more closely related to the GZ01 isolate. It was interesting to find that two (A/G and C/T) of the five mutation loci occurred in the spike protein gene, which caused changes of Asp to Gly and Thr to He in the protein, respectively.Conclusion Attention should be paid to whether these genotype and mutation patterns are related to the virus' s biological activities, epidemic characteristics and host 展开更多
关键词 severe acute respiratory syndrome·coronavirus genotype·polymorphism·phytogeny
原文传递
Clinical analysis of 45 patients with severe acute respiratory syndrome 被引量:1
3
作者 薛晓艳 高占成 +4 位作者 徐钰 丁秀兰 苑丽萍 李文娟 朱继红 《Chinese Medical Journal》 SCIE CAS CSCD 2003年第6期819-822,共4页
Objective To explore the clinical and radiological features of severe acute respiratory syndrome (SARS).Methods Analysis of the clinical presentation, chest radiographs, course of disease and features of severe pneumo... Objective To explore the clinical and radiological features of severe acute respiratory syndrome (SARS).Methods Analysis of the clinical presentation, chest radiographs, course of disease and features of severe pneumonia in 45 SARS patients diagnosed at our hospital in Beijing between April 5 - 20, 2003. Also included is a summation of the clinical features of SARS.Results (1) SARS appears to have high infectivity; (2) the most common symptom is fever; (3) the count of leukocyte is normal or decreased; (4) most patients (35/45, 77.8%) had experienced a 24-hour fever prior to the abnormal chest X-ray changes which showed progression of pulmonary infiltrates within 48 hours in 71.1% (32/45) of the patients and, (5) the percentage of patients who developed severe pneumonia (24. 4%) is higher than those who developed typical pneumonia.Conclusion SARS is a disease with high infectivity and has its own clinical and radiological features. Early recognition, prompt isolation, and appropriate therapy are the key to combate this infection. 展开更多
关键词 infectious atypical pneumonia ·severe acute respiratory syndrome·coronavirus
原文传递
Why COVID-19 is less frequent and severe in children:a narrative review 被引量:1
4
作者 Reza Sinaei Sara Pezeshki +1 位作者 Saeedeh Parvaresh Roya Sinaei 《World Journal of Pediatrics》 SCIE CAS CSCD 2021年第1期10-20,共11页
Background Despite the streaks of severity,severe acute respiratory syndrome-coronavirus-2(SARS-CoV-2)infection is,in general,less frequent and severe in children than in adults.We searched for causal evidence of this... Background Despite the streaks of severity,severe acute respiratory syndrome-coronavirus-2(SARS-CoV-2)infection is,in general,less frequent and severe in children than in adults.We searched for causal evidence of this mystery.Data sources An extensive search strategy was designed to identify papers on coronavirus disease 2019(COVID-19).We searched Ovid MEDLINE,PubMed,EMBASE databases,and Cochrane library and carried out a review on the causes of this dilemma.Results Our searches produced 81 relevant articles.The review showed that children accounted for a lower percentage of reported cases,and they also experienced less severe illness courses.Some potential explanations,including the tendency to engage the upper airway,the different expression in both receptors of angiotensin-converting enzyme and renin-angiotensin system,a less vigorous immune response,the lower levels of interleukin(IL)-6,IL-10,myeloperoxidase,and P-selectin and a higher intracellular adhesion molecule-1,a potential protective role of lymphocytes,and also lung infiltrations might have protective roles in the immune system-respiratory tract interactions.Finally,what have shed light on this under representa-tion comes from two studies that revealed high-titer immunoglobulin-G antibodies against respiratory syncytial virus and mycoplasma pneumonia,may carry out cross-protection against SARS-CoV-2 infection,just like what suggested about the vaccines.Conclusions These results require an in-depth look.Properties of the immune system including a less vigorous adaptive system beside a preliminary potent innate response and a trained immunity alongside a healthier respiratory system,and their interactions,might protect children against SARS-CoV-2 infection.However,further studies are needed to explore other possible causes of this enigma. 展开更多
关键词 CHILDREN coronavirus disease 2019 Severe acute respiratory syndrome-coronavirus 2
原文传递
新冠病毒变异株奥密克戎的变异特点及对免疫学特性的影响 被引量:31
5
作者 李宇 张哲 +3 位作者 杜溪乔 王迎晨 董妥 曲章义 《国际免疫学杂志》 CAS 2022年第1期1-4,共4页
严重急性呼吸综合征冠状病毒2(severe acute respiratory syndrome-coronavirus 2,SARS-CoV-2)新变异株奥密克戎(Omicron)的出现加剧了新型冠状病毒肺炎(coronavirus disease 2019,COVID-19)疫情的传播。奥密克戎变异株首先在非洲发现,P... 严重急性呼吸综合征冠状病毒2(severe acute respiratory syndrome-coronavirus 2,SARS-CoV-2)新变异株奥密克戎(Omicron)的出现加剧了新型冠状病毒肺炎(coronavirus disease 2019,COVID-19)疫情的传播。奥密克戎变异株首先在非洲发现,Pango lineage进化分类系统将该变异株划分为B.1.1.529变异株,世界卫生组织(World Health Organization,WHO)将该变异株确定为"关切病毒株",命名为Omicron变异株。与以前的"关切病毒株"相比,奥密克戎变异株突变位点多,传播速度快,在感染性和免疫学特性上都有很大的变化,存在着免疫逃逸和突破现有疫苗免疫保护作用的风险。在被发现以来的一个多月时间内,该变异株已在全球77个国家和地区迅速传播,引起了全球的广泛关注。文章就奥密克戎变异株发现过程、流行现状、变异特点、免疫逃逸及防控策略等进行概述。 展开更多
关键词 严重急性呼吸综合征冠状病毒2 奥密克戎 免疫逃逸 疫苗
原文传递
中东呼吸综合征冠状病毒(M ERS-CoV)的研究进展 被引量:23
6
作者 阮红梅 张健之 《中国人兽共患病学报》 CAS CSCD 北大核心 2014年第8期848-854,共7页
中东呼吸综合征冠状病毒(Middle East Respiratory Syndrome-Coronavirus,MERS-CoV)是继SARS冠状病毒(SARS-CoV)之后发现的一种能引起人严重急性呼吸道疾病且具有高致死率的新型病毒。目前还没有有效的抗病毒治疗药物或疫苗。现已从主... 中东呼吸综合征冠状病毒(Middle East Respiratory Syndrome-Coronavirus,MERS-CoV)是继SARS冠状病毒(SARS-CoV)之后发现的一种能引起人严重急性呼吸道疾病且具有高致死率的新型病毒。目前还没有有效的抗病毒治疗药物或疫苗。现已从主要流行的中东地区逐渐蔓延至多个国家,具有全球流行的潜在趋势,引起了世界各国的极大关注及众多的调查研究。本文主要对MERS-CoV的传播源及途径、致病机理和抗病毒药物及疫苗等的研究进展做一综述,以期对研制特异的抗病毒药物及疫苗和实施切实有效的预防及控制措施提供参考。 展开更多
关键词 中东呼吸综合征冠状病毒 病毒传播 临床治疗 抗病毒药物 疫苗
下载PDF
基于网络药理学与化学成分研究的连花清瘟胶囊治疗新型冠状病毒肺炎作用机制探讨 被引量:17
7
作者 王旭杰 张菀桐 +7 位作者 王妙然 周忠阳 朱宝琛 李嘉茜 张蕊 张雪雪 李秋艳 翁维良 《世界科学技术-中医药现代化》 CSCD 北大核心 2020年第9期3169-3177,共9页
目的通过网络药理学与分子对接的方法,根据最新研究进展,探讨连花清瘟胶囊治疗新型冠状病毒肺炎(COVID-19)的作用机制。方法纳入相关化学成分研究,从中明确连花清瘟胶囊内所含有的化学成分与入血成分信息;于TCMSP、STITCH数据库搜索药... 目的通过网络药理学与分子对接的方法,根据最新研究进展,探讨连花清瘟胶囊治疗新型冠状病毒肺炎(COVID-19)的作用机制。方法纳入相关化学成分研究,从中明确连花清瘟胶囊内所含有的化学成分与入血成分信息;于TCMSP、STITCH数据库搜索药物作用靶点蛋白后使用UniProt数据库进行相关转化;通过GeneCards、DisGeNET、UniProt数据库筛选COVID-19相关靶点,同时利用PubMed数据库搜索SARS-CoV-2病毒全基因组信息;将药物有效成分作用靶点与疾病靶点比对筛选后构建连花清瘟内有效化合物治疗COVID-19的核心成分-靶点相互作用网络图;利用STRING平台对核心靶点进行PPI网络分析,找出关键靶点信息;使用CytoScape插件ClueGo对核心靶点进行GO功能富集分析与KEGG通路富集分析;将核心成分与相关受体通过Autodock Vina软件进行分子对接分析。结果筛选出连花清瘟胶囊中25个活性成分和146个潜在靶点,新冠肺炎相关靶点为122个,经比对后选出与连花清瘟胶囊治疗新冠肺炎核心作用靶点为26个;通过PPI网络数据选出IL6、IL10、TNF、CCL2、DPP4等核心靶点,KEGG通路与GO富集分析筛选出17条信号通路,7个相关的生物进程;分子对接结果显示大黄素、芦荟大黄素、山奈酚、芦丁等成分同与ACE2结合的SARS-CoV-2刺突蛋白受体结合域结合能较强。结论通过网络药理学证实了连花清瘟胶囊多成分、多靶点、整体调节的作用特点,预测了LQC治疗COVID-19的主要可能的作用机制,为其活性成分研究和实验研究提供理论依据,并有助于阐明连花清瘟胶囊对新冠肺炎的治疗原理。 展开更多
关键词 连花清瘟胶囊 COVID-19 SARS-CoV-2 新冠肺炎 网络药理学
下载PDF
洛匹那韦/利托那韦抗新型冠状病毒治疗的可行性及临床评价 被引量:15
8
作者 闫佳琳 庞文渊 +1 位作者 王乔宇 赵志刚 《中国药业》 CAS 2020年第6期16-20,共5页
目的 评价洛匹那韦/利托那韦抗新型冠状病毒治疗的应用可行性、临床效果及安全性。方法 最近在中国暴发的新型冠状病毒肺炎(简称新冠肺炎)疫情,目前尚无针对性强的抗病毒药物,临床尝试"老药新用",以2003年严重急性呼吸综合征(... 目的 评价洛匹那韦/利托那韦抗新型冠状病毒治疗的应用可行性、临床效果及安全性。方法 最近在中国暴发的新型冠状病毒肺炎(简称新冠肺炎)疫情,目前尚无针对性强的抗病毒药物,临床尝试"老药新用",以2003年严重急性呼吸综合征(SARS)和2012年中东呼吸综合征(MERS)疫情中使用的一线抗病毒药物洛匹那韦/利托那韦来抗新型冠状病毒治疗。分析该药的抗病毒药理作用、临床应用可行性,评价其临床应用效果和安全性。结果 洛匹那韦/利托那韦治疗冠状病毒感染性疾病有一定临床基础,可重建宿主的免疫功能,抗新型冠状病毒有一定疗效,但有较高的耐药屏障。结论 洛匹那韦/利托那韦用于抗新型冠状病毒治疗可行,临床疗效较好,但应用期间要加强药学监护,尤其是合并用药和特殊人群应用时,注重安全、合理用药。 展开更多
关键词 洛匹那韦/利托那韦 新型冠状病毒 新型冠状病毒肺炎 抗病毒治疗 药学监护
下载PDF
Establishment of a fluorescent polymerase chain reaction method for the detection of the SARS-associated coronavirus and its clinical application 被引量:9
9
作者 吴新伟 程钢 +7 位作者 狄飚 尹爱华 何蕴韶 王鸣 周新宇 何丽娟 罗凯 杜琳 《Chinese Medical Journal》 SCIE CAS CSCD 2003年第7期988-990,共3页
Objective To establish a fluorescent polymerase chain reaction (F PCR) method for detecting the coronavirus related to severe acute respiratory syndrome (SARS) and to evaluate its value for clinical application Me... Objective To establish a fluorescent polymerase chain reaction (F PCR) method for detecting the coronavirus related to severe acute respiratory syndrome (SARS) and to evaluate its value for clinical application Methods The primers and the fluorescence labeled probe were designed and synthesized according to the published sequence of the SARS associated coronavirus genes A F PCR diagnosis kit for detecting the coronavirus was developed, and 115 clinical nasopharyngeal gargling liquid samples were tested Results The sequence of PCR amplified products completely matched the related sequence of the SARS associated coronavirus genome Forty nine out of 67 samples from identified SARS patients and 8 of 18 samples from persons having close contact with SARS patients showed positive results All 30 samples from healthy controls were negative Conclusion The F PCR method established may be a rapid, accurate and efficient way for screening and for the early diagnosis of SARS patients 展开更多
关键词 severe acute respiratory syndrome coronavirus polymerase chain reaction ·nasopharyngeal gargling liquid
原文传递
Molecular biological analysis of genotyping and phylogeny of severe acute respiratory syndrome associated coronavirus 被引量:6
10
作者 王志刚 李兰娟 +9 位作者 罗芸 张俊彦 王敏雅 程苏云 张严峻 王晓萌 卢亦愚 吴南屏 梅玲玲 王赞信 《Chinese Medical Journal》 SCIE CAS CSCD 2004年第1期42-48,共7页
Background SARS-CoV is the causative agent of severe acute respiratory syndrome (SARS) which has been associated with outbreaks of SARS in Guangdong,Hong Kong and Beijing of China,and other regions worldwide. SARS-C... Background SARS-CoV is the causative agent of severe acute respiratory syndrome (SARS) which has been associated with outbreaks of SARS in Guangdong,Hong Kong and Beijing of China,and other regions worldwide. SARS-CoV from human has shown some variations but its origin is still unknown. The genotyping and phylogeny of SARS-CoV were analyzed and reported in this paper. Methods Full or partial genomes of 44 SARS-CoV strains were collected from GenBank. The genotype,single nucleotide polymorphism and phylogeny of these SARS-CoV strains were analyzed by molecular biological,bioinformatic and epidemiological methods. Results There were 188 point mutations in the 33 virus full genomes with the counts of mutation mounting to 297. Further analysis was carried out among 36 of 188 loci with more than two times of mutation. All the 36 mutation loci occurred in coding sequences and 22 loci were non-synonymous. The gene mutation rates of replicase 1AB,S2 domain of spike glycoprotein and nucleocapsid protein were lower (0.079%-0.103%). There were 4 mutation loci in S1 domain of spike glycoprotein. The gene mutation rate of ORF10 was the highest (3.333%) with 4 mutation loci in this small domain (120 bp) and 3 of 4 loci related to deletion mutation. By bioinformatics processing and analysis,the nucleotides at 7 loci of genome (T∶T∶A∶G∶T∶C∶T/C∶G∶G∶A∶C∶T∶C) can classify SARS-CoV into two types. Therefore a novel definition is put forward that according to these 7 loci of mutation,40 strains of SARS-CoV in GenBank can be grouped into two genotypes,T∶T∶A∶G∶T∶C∶T and C∶G∶ G∶A∶ C∶T∶C,and named as SARS-CoV Yexin genotype and Xiaohong genotype. The two genotypes can be further divided into some sub-genotypes. These genotypes can also be approved by phylogenetic tree of three levels of 44 loci of mutation, spike glycoprotein gene and complete genome sequence. Compared to various strains among SARS-CoV Yexin genotype and Xiaohong genotype,GD01 strain of Yexin genotype is mo 展开更多
关键词 severe acute respiratory syndrome·coronavirus·genotype·phylogeny
原文传递
Antiviral activity of cepharanthine against severe acute respiratory syndrome coronavirus in vitro 被引量:10
11
作者 ZHANGChuan-hai WANGYi-fei +9 位作者 LIUXin-jian LUJia-hai QIANChui-wen WANZhuo-yue YANXin-ge ZHENGHuan-ying ZHANGMei-ying XIONGSheng LIJiu-xiang QIShu-yuan 《Chinese Medical Journal》 SCIE CAS CSCD 2005年第6期493-496,共4页
Severe acute respiratory syndrome(SARS) is the first severe viral epidemic we encountered his century,which once spread in more than thirty countriesin2003.1 The etiological agent of SARS has beenc onfirmed to be a n... Severe acute respiratory syndrome(SARS) is the first severe viral epidemic we encountered his century,which once spread in more than thirty countriesin2003.1 The etiological agent of SARS has beenc onfirmed to be a novel coronavirus,namely SARS coronavirus(SARS-CoV),2,3 and the first outbreak of SARS has been successfully controlled world wide,but the identification of SARS-CoV isolated from wildanimals,the emergence of some sporadic SARS cases laterafter that outbreak,all suggest that the recurrence of such an epidemic is not unlikely in the future.In this case,development of SARS vaccines and specific drugs is undoubtedlyessential to the control and prevention from the possible outbreak.4,5 展开更多
关键词 CEPHARANTHINE severe acute respiratory syndrome coronavirus antiviral activity
原文传递
人类冠状病毒概况及其药物治疗研究进展 被引量:10
12
作者 王子民 王雪雅 +9 位作者 荆晓光 远东涛 宛磊 李智浩 吴大龙 张世魁 王斌 宋松根 武娜 魏茜 《解放军医学杂志》 CAS CSCD 北大核心 2020年第4期375-383,共9页
冠状病毒(CoV)主要在鸟类和哺乳动物中引起局部感染,最近几十年,已有证据显示其可感染人类。高致病性冠状病毒[包括严重急性呼吸综合征冠状病毒(SARS-CoV)、中东呼吸综合征冠状病毒(MERS-CoV)]是人畜共患病毒,对公共卫生构成重大威胁。... 冠状病毒(CoV)主要在鸟类和哺乳动物中引起局部感染,最近几十年,已有证据显示其可感染人类。高致病性冠状病毒[包括严重急性呼吸综合征冠状病毒(SARS-CoV)、中东呼吸综合征冠状病毒(MERS-CoV)]是人畜共患病毒,对公共卫生构成重大威胁。严重急性呼吸综合征冠状病毒2(SARS-CoV-2)通过密切接触在人与人之间传播所引起的新型冠状病毒肺炎(COVID-19)已经严重威胁人类的健康和安全,部分患者可发展为急性呼吸窘迫综合征和多脏器衰竭,发病率及病死率均较高。该文就冠状病毒的结构、流行病学、免疫学以及治疗药物进行综述,希望能为本病的预防、控制和治疗提供参考。 展开更多
关键词 冠状病毒 严重急性呼吸综合征 中东呼吸综合征 严重急性呼吸综合征冠状病毒2 流行病学 瑞德西韦 环孢素A
下载PDF
Antiviral Properties of Traditional Chinese Medicine against Coronavirus: Research Clues for Coronavirus Disease-2019 被引量:7
13
作者 Xu-Jie Wang Jia-Xi Li +8 位作者 Miao-Ran Wang Zhong-Yang Zhou Bao-Chen Zhu Xue-Xue Zhang Rui Zhang Wei Tang Yu-Fei Wu Wan-Tong Zhang Qiu-Yan Li 《World Journal of Traditional Chinese Medicine》 2020年第2期132-138,共7页
The objective of this study was to provide research clues for the prevention and treatment of coronavirus disease-2019(COVID-19)and coronavirus(Co V)infection using Traditional Chinese Medicine(TCM).A review on resear... The objective of this study was to provide research clues for the prevention and treatment of coronavirus disease-2019(COVID-19)and coronavirus(Co V)infection using Traditional Chinese Medicine(TCM).A review on research and clinical trials that using TCM extracts and active ingredients against Co V was performed,and a table of TCM agents and their effects on Co V were summarized.Relevant analysis was performed and visual expression of the data included summarizing the types of TCM and treatment methods for COVID-19.TCM fighting against Co V is mainly used in the lung and heart channels,and its medicinal properties are mainly cold and mild,while its taste is mainly bitter and sweet.The majority of research focused on treatments that clear away heat and toxic materials and those that strengthen body resistance and tonify deficiencies.TCM has unique advantages to fight against Co V.The development of new anti-Co V therapy using TCM is of great significance for the prevention and treatment of COVID-19 pneumonia and various viral infectious diseases. 展开更多
关键词 2019-novel coronavirus coronavirus coronavirus disease-19 novel coronavirus pneumonia severe acute respiratory syndrome-coronavirus-2 Traditional Chinese Medicine
原文传递
新型冠状病毒变异株对新冠病毒疫苗免疫效力的影响 被引量:9
14
作者 张哲 马莹 +2 位作者 董妥 王迎晨 曲章义 《国际免疫学杂志》 CAS 2021年第5期487-492,共6页
随着严重急性呼吸综合征冠状病毒2(severe acute respiratory syndrome-coronavirus 2,SARS-CoV-2)疫苗的研发上市,接种疫苗已成为阻断新型冠状病毒肺炎(corona virus disease 2019,COVID-19)传播的最有效途径。然而,SARS-CoV-2变异株... 随着严重急性呼吸综合征冠状病毒2(severe acute respiratory syndrome-coronavirus 2,SARS-CoV-2)疫苗的研发上市,接种疫苗已成为阻断新型冠状病毒肺炎(corona virus disease 2019,COVID-19)传播的最有效途径。然而,SARS-CoV-2变异株的不断出现对疫苗的免疫效力带来了一定影响,引起了人们的广泛关注。文章对目前主要出现的SARS-CoV-2变异株及其变异位点进行了总结,分析了SARS-CoV-2变异株对疫苗免疫保护效力的影响。 展开更多
关键词 急性呼吸综合征冠状病毒2 新型冠状病毒肺炎2019 病毒突变 疫苗效力 刺突蛋白
原文传递
法匹拉韦治疗新型冠状病毒肺炎的可行性分析 被引量:6
15
作者 张竞文 胡欣 金鹏飞 《中国药业》 CAS 2020年第6期20-24,共5页
目的 探讨法匹拉韦治疗新型冠状病毒肺炎(COVID-19)的临床可行性。方法 针对从已上市/已进入临床研究的药物中挖掘出的、可能具有抗新型冠状病毒(SARS-CoV-2)作用的药物之一法匹拉韦,结合其作用机制、临床应用史和临床疗效及安全性试验... 目的 探讨法匹拉韦治疗新型冠状病毒肺炎(COVID-19)的临床可行性。方法 针对从已上市/已进入临床研究的药物中挖掘出的、可能具有抗新型冠状病毒(SARS-CoV-2)作用的药物之一法匹拉韦,结合其作用机制、临床应用史和临床疗效及安全性试验进行可行性分析。结果 与结论法匹拉韦为国内首个在疫情期间批准上市的抗病毒药物,适应证为成人新型或再次流行的流感。经可行性分析,其对多种RNA病毒疗效显著,且不良反应也较少,从理论上对SARS-CoV-2也有作用,但有待更大规模的临床试验进行验证。 展开更多
关键词 新型冠状病毒 严重急性呼吸综合征 新型冠状病毒肺炎 法匹拉韦 可行性
下载PDF
新型冠状病毒灭活疫苗接种后的针后贴和受种者手部标本核酸检测情况的研究 被引量:6
16
作者 樊高威 梁玉芳 +8 位作者 马雪 刘冰 王京 路璐 李桂芹 金雯 顾佳 王明刚 王清涛 《中华预防医学杂志》 CAS CSCD 北大核心 2021年第3期406-408,共3页
从2021年1月30日接种新型冠状病毒灭活疫苗的首都医科大学附属北京朝阳医院工作人员中选择28位受试者作为研究对象进行研究,在疫苗接种前后分别对受种者的双手进行采样核酸检测的同时,对接种疫苗后粘贴在接种部位的针后贴进行核酸检测... 从2021年1月30日接种新型冠状病毒灭活疫苗的首都医科大学附属北京朝阳医院工作人员中选择28位受试者作为研究对象进行研究,在疫苗接种前后分别对受种者的双手进行采样核酸检测的同时,对接种疫苗后粘贴在接种部位的针后贴进行核酸检测。接种疫苗前,受种者双手表面采集的标本核酸检测结果均为阴性。接种疫苗后,受种者双手表面采集的标本核酸检测结果阳性共3例,核酸检测结果可疑共8例,阳性率占10.7%;共收集25例使用过的针后贴标本,核酸检测结果阳性24例,核酸检测结果可疑1例,阳性率占96%。新型冠状病毒灭活疫苗接种的针后贴存在核酸污染的风险。 展开更多
关键词 新型冠状病毒 灭活疫苗 核酸检测 受种者
原文传递
全球新型冠状病毒疫苗研发进展 被引量:5
17
作者 梁慧刚 朱小丽 +2 位作者 黄翠 周缘 陈新文 《军事医学》 CAS 2022年第4期241-248,共8页
2019年底暴发的新型冠状病毒肺炎疫情迅速席卷全球,造成了大量人员感染和死亡。应对疫情最有效的举措之一是加快疫苗研发与大规模临床应用。过去一年多以来,全球科学家为新型冠状病毒疫苗的研发与应用开展了大量的工作。该文综述了病毒... 2019年底暴发的新型冠状病毒肺炎疫情迅速席卷全球,造成了大量人员感染和死亡。应对疫情最有效的举措之一是加快疫苗研发与大规模临床应用。过去一年多以来,全球科学家为新型冠状病毒疫苗的研发与应用开展了大量的工作。该文综述了病毒灭活疫苗、减毒活病毒疫苗、亚单位疫苗、病毒载体疫苗、核酸疫苗等研发的主要技术路线,分析了全球新型冠状病毒疫苗研发态势,包括获批的新冠灭活疫苗、mRNA疫苗、病毒载体疫苗、蛋白亚单位疫苗,以及进展较快的病毒样颗粒疫苗等。 展开更多
关键词 新型冠状病毒肺炎 严重急性呼吸综合征冠状病毒2 疫苗
原文传递
家猫ACE2基因克隆、测序及生物信息学分析 被引量:6
18
作者 王冲 谭亚娣 +1 位作者 郭爱珍 陈焕春 《武汉大学学报(理学版)》 CAS CSCD 北大核心 2005年第6期739-743,共5页
本研究从家猫组织中扩增并鉴定血管紧张素转换酶2(angiotensin-converting enzyme 2,ACE2)基因,为阐明SARS相关冠状病毒(SARS-CoV)感染家猫的机制提供理论依据.从家猫肺脏中提取总RNA,以Oligo dT-Adaptor为引物合成第一链cDNA,根据人及... 本研究从家猫组织中扩增并鉴定血管紧张素转换酶2(angiotensin-converting enzyme 2,ACE2)基因,为阐明SARS相关冠状病毒(SARS-CoV)感染家猫的机制提供理论依据.从家猫肺脏中提取总RNA,以Oligo dT-Adaptor为引物合成第一链cDNA,根据人及小鼠的ACE2基因mRNA序列设计系列引物,通过聚合酶链式反应,分段扩增出家猫ACE2基因的编码区的特异性片段并测序鉴定.家猫ACE2基因mRNA编码区共包括2 418个核苷酸,推测编码蛋白含805个氨基酸残基.其氨基酸序列与人、小鼠、大鼠ACE2氨基酸序列的同源性分别达到85%,81%和81%.利用多种生物信息学工具软件对家猫ACE2蛋白的理化及生物学性质进行分析.比较人、家猫、果子狸、小鼠、大鼠等ACE2序列中与SARS-CoV结合有关的3个功能区,发现家猫ACE2与人ACE2的同源性最高,提示家猫ACE2在SARS病毒跨种感染中可能发挥重要作用. 展开更多
关键词 家猫 血管紧张素转换酶2 序列分析 生物信息学 严重急性呼吸系统综合征冠状病毒
下载PDF
SARS-CoV推测N蛋白功能结构的生物信息学研究 被引量:3
19
作者 刘树春 赵雨杰 +1 位作者 张学 罗阳 《中国生物工程杂志》 CAS CSCD 2003年第12期99-102,共4页
目的 :利用生物信息学方法理论分析不同地区来源的SARS冠状病毒 (SARS CoV)推断N蛋白的基因组与氨基酸序列的差异及分子生物学特征以及基因突变对蛋白结构功能的影响。方法 :针对GenBank上发布的来自不同国家地区的 1 5条SARS CoV基因... 目的 :利用生物信息学方法理论分析不同地区来源的SARS冠状病毒 (SARS CoV)推断N蛋白的基因组与氨基酸序列的差异及分子生物学特征以及基因突变对蛋白结构功能的影响。方法 :针对GenBank上发布的来自不同国家地区的 1 5条SARS CoV基因组序列 ,采用生物信息学软件分析其推测N蛋白的CDS和氨基酸序列 ,分别找出突变位点并预测其等电点及功能结构域。结果 :SARS CoV推测N蛋白基因组序列存在 5个变异位点导致蛋白序列有 4个位点发生突变。在该蛋白上发现四个有意义的低成分复杂性区域 ;未发现卷曲螺旋、跨膜螺旋和信号肽序列。基因突变造成 4条序列在功能位点数量上减少 ,但未影响抗原决定簇。预测发现两个保守的Domain和一个丝氨酸富集区。结论 :不同地区来源的 1 5条推测N蛋白序列的变异很少。基因突变导致部分序列功能位点数量发生改变 ,但未影响抗原决定簇的数量。 展开更多
关键词 严重急性呼吸综合征 冠状病毒 差异比较 核衣壳蛋白 生物信息学
下载PDF
2019冠状病毒病的口腔症状及机制研判与探讨 被引量:1
20
作者 王菖与 成姝婷 《病毒学报》 CAS CSCD 北大核心 2023年第3期805-815,共11页
口腔健康是全身健康的重要组成部分之一,口腔不仅是消化系统的起始部位,还与呼吸系统直接相通。受到2019冠状病毒病(Coronavirus disease 2019, COVID-19)的影响,口腔医疗资源出现疫情下的短缺,而对COVID-19患者的口腔症状的普及不到位... 口腔健康是全身健康的重要组成部分之一,口腔不仅是消化系统的起始部位,还与呼吸系统直接相通。受到2019冠状病毒病(Coronavirus disease 2019, COVID-19)的影响,口腔医疗资源出现疫情下的短缺,而对COVID-19患者的口腔症状的普及不到位也造成口腔治疗时存在医源性感染的潜在风险。现阶段关于COVID-19的研究多集中在呼吸系统、神经系统、心血管系统和免疫系统领域,虽有关于COVID-19患者出现口腔感染迹象的报道,但目前对口腔潜在影响的研究较少。本文将针对COVID-19致病病毒—严重急性呼吸系统综合征冠状病毒2型(Severe acute respiratory syndrome-coronavirus-2, SARS-CoV-2)的感染特点、COVID-19患者的口腔症状及机制进行综述,强调从口腔领域研究COVID-19的必要性,望有助于预防疾病、控制传播、筛查诊断和治疗。 展开更多
关键词 2019冠状病毒病 严重急性呼吸系统综合征冠状病毒2型 口腔疾病 机制
原文传递
上一页 1 2 51 下一页 到第
使用帮助 返回顶部